Type	Entity	Source evidence	Confidence	Extractor
gene	CD19	“CD19 chimeric antigen receptor T-cell (CAR-T) therapy is a pivotal part of the treatment algorithm for large B-cell lymphoma (LBCL) in the second- and third-line settings based on numerous clinical trials.”	0.98	hgnc_dict_v1
phenotype	lymphoma	“Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOS.”	0.98	phenotype_alias_lexicon_v2

CD19 Directed CAR T Therapy for Transformed Follicular Lymphoma: A CIBMTR Analysis.

PMID 40762207 | PMCID PMC12582634 | DOI 10.1002/ajh.70027 · American journal of hematology · 2025 · 2 validated mentions

View on PubMed ↗All extracted evidence

Evidence preview

Type	Entity	Source evidence	Confidence	Extractor
gene	CD19	“CD19 Directed CAR T Therapy for Transformed Follicular Lymphoma: A CIBMTR Analysis.”	0.98	hgnc_dict_v1
phenotype	lymphoma	“CD19 Directed CAR T Therapy for Transformed Follicular Lymphoma: A CIBMTR Analysis.”	0.98	phenotype_alias_lexicon_v2

CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives.

PMID 31690821 | DOI 10.1038/s41375-019-0615-5 · Leukemia · 2019 · 3 validated mentions

View on PubMed ↗All extracted evidence

Evidence preview

Type	Entity	Source evidence	Confidence	Extractor
gene	CD19	“CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives.”	0.98	hgnc_dict_v1
phenotype	lymphoma	“CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives.”	0.98	phenotype_alias_lexicon_v2
phenotype	leukemia	“CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives.”	0.98	phenotype_alias_lexicon_v2

Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.

PMID 31446199 | DOI 10.1016/j.bbmt.2019.08.015 · Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2019 · 2 validated mentions

View on PubMed ↗All extracted evidence

Evidence preview

Type	Entity	Source evidence	Confidence	Extractor
gene	CD19	“To address these issues, representatives of the American Society of Transplantation and Cellular Therapy convened to recognize and address key issues surrounding the clinical application of CD19 CAR T cell therapy in B cell lymphomas, in collaboration with worldwide experts.”	0.98	hgnc_dict_v1
phenotype	lymphoma	“Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.”	0.98	phenotype_alias_lexicon_v2

A multicolour flow cytometric assay for c-MYC protein in B-cell lymphoma.

PMID 29769234 | DOI 10.1136/jclinpath-2018-205075 · Journal of clinical pathology · 2018 · 2 validated mentions

View on PubMed ↗All extracted evidence

Evidence preview

Type	Entity	Source evidence	Confidence	Extractor
gene	CD19	“Cell suspensions were obtained and c-MYC staining was performed in combination with CD45 and CD19 and, in some samples, CD10.”	0.98	hgnc_dict_v1
phenotype	lymphoma	“A multicolour flow cytometric assay for c-MYC protein in B-cell lymphoma.”	0.98	phenotype_alias_lexicon_v2

Plasmablastic Lymphoma: A Review of Current Knowledge and Future Directions.

PMID 26357515 | PMCID PMC4555447 | DOI 10.1155/2015/315289 · Advances in hematology · 2015 · 3 validated mentions

View on PubMed ↗All extracted evidence

Evidence preview

Type	Entity	Source evidence	Confidence	Extractor
gene	CD19	“The introduction of genes encoding artificial receptors called chimeric antigen receptors (CARs) and CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials.”	0.98	hgnc_dict_v1
phenotype	lymphoma	“Plasmablastic Lymphoma: A Review of Current Knowledge and Future Directions.”	0.98	phenotype_alias_lexicon_v2
phenotype	multiple myeloma	“PBL remains a diagnostic challenge due to its peculiar morphology and an immunohistochemical profile similar to plasma cell myeloma (PCM).”	0.93	phenotype_alias_lexicon_v2

De Novo CD5 Negative Blastic Mantle Cell Lymphoma Presented with Massive Bone Marrow Necrosis without Adenopathy or Organomegaly.

PMID 26347832 | PMCID PMC4546951 | DOI 10.1155/2015/146598 · Case reports in hematology · 2015 · 2 validated mentions

View on PubMed ↗All extracted evidence

Evidence preview

Type	Entity	Source evidence	Confidence	Extractor
gene	CD19	“The pathologic features showed blastoid variant of MCL and flow cytometry showed that the tumor cells were CD5-, CD19+, CD20+, FMC-7+, CD23-, and lambda light chain restricted.”	0.98	hgnc_dict_v1
phenotype	lymphoma	“De Novo CD5 Negative Blastic Mantle Cell Lymphoma Presented with Massive Bone Marrow Necrosis without Adenopathy or Organomegaly.”	0.98	phenotype_alias_lexicon_v2

Immunophenotyping of peripheral blood lymphocytes in Saudi men.

PMID 11874863 | PMCID PMC119953 | DOI 10.1128/cdli.9.2.279-281.2002 · Clinical and diagnostic laboratory immunology · 2002 · 5 validated mentions

View on PubMed ↗All extracted evidence

Evidence preview

Type	Entity	Source evidence	Confidence	Extractor
gene	CD19	“We investigated the expression of T-cell markers (CD3, CD4, and CD8), B cells (CD19), and natural killer cells (CD16 and CD56).”	0.98	hgnc_dict_v1
phenotype	lymphoma	“Flow cytometry is an important tool for the diagnosis and follow-up of immunodeficiency patients, as well as for patients with leukemia and lymphoma.”	0.98	phenotype_alias_lexicon_v2
gene	CD4	“We investigated the expression of T-cell markers (CD3, CD4, and CD8), B cells (CD19), and natural killer cells (CD16 and CD56).”	0.98	hgnc_dict_v1
phenotype	leukemia	“Flow cytometry is an important tool for the diagnosis and follow-up of immunodeficiency patients, as well as for patients with leukemia and lymphoma.”	0.98	phenotype_alias_lexicon_v2